Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 23:17:E69.
doi: 10.5888/pcd17.200317.

Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic

Mark A Strand  1   2 , Jeffrey Bratberg  3 , Heidi Eukel  1 , Mark Hardy  4 , Christopher Williams  5
Affiliations

Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic

Mark A Strand et al. Prev Chronic Dis. .

Erratum in

Abstract

Community pharmacists assist patients to manage disease and prevent complications. Despite the enormous challenge the coronavirus disease 2019 (COVID-19) pandemic has dealt to the health care system, community pharmacists have maintained the delivery of critical health services to communities, including those most at risk for COVID-19. Community pharmacists are in a key position to deliver priority pandemic responses including point-of-care testing for chronic disease management, vaccinations, and COVID-19 testing.

PubMed Disclaimer

References

    1. Bennett M, Goode J-VR. Recognition of community-based pharmacist practitioners: essential health care providers. J Am Pharm Assoc (2003) 2016;56(5):580–3. 10.1016/j.japh.2016.04.566 - DOI - PubMed
    1. Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. Int J Pharm Pract 2013;21(6):349–61. 10.1111/ijpp.12041 - DOI - PubMed
    1. Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm 2013;19(5):408–16. 10.18553/jmcp.2013.19.5.408 - DOI - PMC - PubMed
    1. Ifeanyi Chiazor E, Evans M, van Woerden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. Value Health Reg Issues 2015;7:9–21. 10.1016/j.vhri.2015.03.002 - DOI - PubMed
    1. Qato DM, Zenk S, Wilder J, Harrington R, Gaskin D, Alexander GC. The availability of pharmacies in the United States: 2007-2015. PLoS One 2017;12(8):e0183172. 10.1371/journal.pone.0183172 - DOI - PMC - PubMed

MeSH terms